Gardner Denver (GDI) Jumps as Deal with SPX (SPW) Near
Tweet Send to a Friend
Get Alerts GDI Hot Sheet
Down)
Trade GDI Now!
Shares of Gardner Denver, Inc. (NYSE: GDI) are sharply higher early Tuesday following reports from Reuters that SPX Corp (NYSE: SPW) is in exclusive talks to acquire the company in a deal that could be finalized by the end of the year.
Private equity bidders, including KKR & Co LP (NYSE: KKR), Advent International and a consortium of TPG Capital LP and Onex Corp, are also interested in the company although Gardner Denver prefers to do a deal with SPX.
A potential sale of Gardner Denver is not new news. In October, Gardner Denver hired Goldman, Sachs & Co. to explore strategic alternatives, including a possible sale.
A price SPX would pay for Gardner Denver was not mentioned by Reuters, although a separate report from the Wall Street Journal said SPX offered "several dollars" more than the low to mid-$70s bids PE firms bid for the company. An SPX deal would likely come as a mixture of cash and stock.
Shares of Gardner Denver last traded at $71.69, up 5.2 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Private equity bidders, including KKR & Co LP (NYSE: KKR), Advent International and a consortium of TPG Capital LP and Onex Corp, are also interested in the company although Gardner Denver prefers to do a deal with SPX.
A potential sale of Gardner Denver is not new news. In October, Gardner Denver hired Goldman, Sachs & Co. to explore strategic alternatives, including a possible sale.
A price SPX would pay for Gardner Denver was not mentioned by Reuters, although a separate report from the Wall Street Journal said SPX offered "several dollars" more than the low to mid-$70s bids PE firms bid for the company. An SPX deal would likely come as a mixture of cash and stock.
Shares of Gardner Denver last traded at $71.69, up 5.2 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Bausch & Lomb near deal to sell to Valeant Pharmaceuticals (VRX) - WSJ
- China Approves Acquisition of Heinz (HNZ) by Berkshire Hathaway and 3G Capital
- Valeant (VRX) Continues Deal Hunt; Close to Buying Bausch & Lomb for $9B
Create E-mail Alert Related Categories
Mergers and Acquisitions, Private Equity, Rumors
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
